Herantis Pharma
2 known investors
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
Founders & leadership
AV
Antti VuolantoCEO
Investors · 2
In the news
- Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096manilatimes.net · 2026
- Herantis Pharma releases 2H and FY 2025 report today - BioSpacebiospace.com · 2026
- Funding boost for promising treatment | Parkinson's UKparkinsons.org.uk · 2026
- Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 - BioSpacebiospace.com · 2026
- Herantis Pharma raises EUR 5.2 million - NLSnordiclifescience.org · 2025